Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News SQI Diagnostics Inc. V.SQD

Alternate Symbol(s):  SQIDF

SQI Diagnostics are leaders in the science of lung health. We develop and manufacture respiratory health and precision medicine tests that run on SQI's automated systems. Our tests simplify and improve COVID19 antibody monitoring, Rapid Acute Lung Injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada and Europe. More than half of its revenues come from the United States.


Recent & Breaking News (TSXV:SQD)

SQI DIAGNOSTICS COMPLETES ACQUISITION OF PRECISION BIOMONITORING'S HUMAN DIAGNOSTIC TESTING BUSINESS

PR Newswire February 14, 2022

SQI DIAGNOSTICS PROVIDES UPDATE ON PREVIOUSLY ANNOUNCED ASSET PURCHASE TRANSACTION WITH PBI DIAGNOSTICS

PR Newswire February 9, 2022

SQI DIAGNOSTICS PROVIDES UPDATE ON PREVIOUSLY ANNOUNCED ASSET PURCHASE TRANSACTION WITH PRECISION BIOMONITORING

PR Newswire February 9, 2022

SQI Diagnostics Reports Fourth Quarter and Fiscal 2021 Results

PR Newswire January 26, 2022

SQI Diagnostics Inc Signs MOU with UK-Based Owlstone Medical

PR Newswire January 24, 2022

SQI Diagnostics Inc Congratulates its Partner UHN for Winning $24 Million Award from Government of Canada

PR Newswire January 13, 2022

IIROC Trading Resumption - SQD

PR Newswire January 10, 2022

SQI ENTERS DEFINITIVE AGREEMENT TO ACQUIRE PRECISION BIOMONITORING'S HUMAN DIAGNOSTIC TESTING BUSINESS

PR Newswire January 10, 2022

IIROC Trading Halt - SQD

PR Newswire January 10, 2022

SQI Diagnostics Inc. Closes Second and Final Tranche of Private Placement

PR Newswire November 8, 2021

SQI Diagnostics Inc. Closes First Tranche of Private Placement with Insider Participation

PR Newswire November 1, 2021

SQI Diagnostics Inc. Responds to Change in FDA Priorities in Emergency Use Authorization

PR Newswire October 19, 2021

SQI Diagnostics Inc. Announces Private Placement with Insider Participation

PR Newswire September 24, 2021

SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options

PR Newswire September 13, 2021

SQI Diagnostics Inc. Announces Grant of Stock Options

PR Newswire August 30, 2021

SQI Diagnostics Reports Third Quarter 2021 Results

PR Newswire August 18, 2021

FDA Stops Emergency Use Authorization Review of SQI Diagnostics RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients

PR Newswire July 23, 2021

SQI Diagnostics and AZOVA sign distribution agreement to sell SQI's COVID-19 HOME Antibody Test

PR Newswire July 15, 2021

SQI Diagnostics Inc. Announces $3.9 Million Funding via Warrant Exercise by Insiders

Canada NewsWire June 15, 2021

SQI Diagnostics Inc. Announces Grant of Stock Options

Canada NewsWire May 27, 2021